On December 20, 2019 Heska Corporation (NASDAQ: HSKA – News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, reported that Kevin Wilson, Heska’s President & Chief Executive Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 at 3 p.m. PT in San Francisco, CA (Press release, Heska, DEC 20, 2019, View Source [SID1234552561]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Management will be available for one-on-one meetings on January 15th and 16th. To schedule a meeting, please contact J.P. Morgan at 1×[email protected] or Heska Investor Relations at [email protected].
A live webcast of the company’s presentation can be accessed at View Source and a live webcast of the subsequent question and answer session can be accessed at View Source.
The webcast will be archived shortly after the event, and a replay will be available on the company’s website for 90 days following the conference. A copy of the presentation will be available on Heska’s website at View Source